Pathfinders in Biopharma
En podcast af RBC Capital Markets
46 Episoder
-
Uncertainty reigns, but opportunity persists for biotech’s 2025
Udgivet: 7.2.2025 -
Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments
Udgivet: 22.11.2024 -
Former Investor Who Chose Broadcasting Over Biotech ETFs
Udgivet: 30.9.2024 -
Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?
Udgivet: 29.8.2024 -
Shots-on-Goal Licensing Company Aims for Breakthroughs
Udgivet: 19.7.2024 -
Why Biopharma Needs to Tell Better Stories on Novel Drugs
Udgivet: 11.7.2024 -
Venture capital velocity: What’s driving renewed momentum in biotech?
Udgivet: 8.7.2024 -
Pharma Understands Phase One Data – But Does the Market?
Udgivet: 21.6.2024 -
Davern Capital sees GLP-1 Opportunities Beyond Obesity
Udgivet: 14.6.2024 -
Betting on Healthcare’s Future Hits – and Misses
Udgivet: 10.6.2024 -
Innovation and an Aging Population Drive MedTech
Udgivet: 5.6.2024 -
Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing
Udgivet: 3.6.2024 -
Biotech with a Mission to Target Unmet Cancer Needs
Udgivet: 31.5.2024 -
The M&A Pool Set to Accelerate Biotech Innovation
Udgivet: 3.4.2024 -
How PIPEs finally unblocked biotech’s funding flows
Udgivet: 29.3.2024 -
Disruptive Forces in Healthcare: Why HCIT is finally set to bounce back
Udgivet: 7.3.2024 -
Will the Biotech Rebound Run into Pricing Policy Obstacles?
Udgivet: 27.2.2024 -
Few IPOs but plenty of follow-on for biotech in 2023
Udgivet: 22.1.2024 -
U.S. Outlook: Will the US economy achieve a soft landing in 2024?
Udgivet: 29.12.2023 -
Raising Venture Capital: A New Playbook for A New Era in Biotech
Udgivet: 22.11.2023
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
